Aquestive Therapeutics (AQST) P/E (2018 - 2026)
Aquestive Therapeutics (AQST) P/E from Jul 25, 2018 to Jul 21, 2026. The TTM Aquestive Therapeutics (AQST) P/E is -6.86. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Aquestive Therapeutics (AQST)
| Year | P/E | Change |
|---|---|---|
| 2026 | -6.86 | -19.84% |
| 2025 | -8.55 | +16.43% |
| 2024 | -7.35 | -25.33% |
| 2023 | -9.84 | +1599.07% |
| 2022 | -0.58 | -73.35% |
| 2021 | -2.17 | -33.28% |
| 2020 | -3.26 | +40.96% |
| 2019 | -2.31 | +12.31% |
| 2018 | -2.06 | N/A |
Comparison Aquestive Therapeutics (AQST) P/E with competitors
Aquestive Therapeutics (AQST) P/E is -6.86.